FRM
Fox Run Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,372
| Closed | -$382K | – | 1293 |
|
|
2025
Q1 | $382K | Buy |
11,372
+2,751
| +32% | +$92.3K | 0.06% | 600 |
|
|
2024
Q4 | $338K | Sell |
8,621
-11,123
| -56% | -$436K | 0.06% | 589 |
|
|
2024
Q3 | $777K | Buy |
19,744
+13,057
| +195% | +$514K | 0.17% | 203 |
|
|
2024
Q2 | $261K | Buy |
+6,687
| New | +$261K | 0.05% | 585 |
|
|
2024
Q1 | – | Sell |
-6,595
| Closed | -$304K | – | 1103 |
|
|
2023
Q4 | $304K | Buy |
+6,595
| New | +$304K | 0.08% | 488 |
|
|
2023
Q1 | – | Sell |
-12,975
| Closed | -$512K | – | 964 |
|
|
2022
Q4 | $512K | Buy |
12,975
+3,244
| +33% | +$128K | 0.21% | 168 |
|
|
2022
Q3 | $351K | Buy |
+9,731
| New | +$351K | 0.14% | 300 |
|